Metastasis ovarian cancer endometrial cancer vulvar neoplasms. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Tumor Cells, Cultured Endometrium Lymph Nodes Neoplastic Stem Cells Ovary Epithelial Cells Neoplastic Cells, Circulating Breast

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases73

Vulvar Neoplasms Endometrial Neoplasms Ovarian Neoplasms Neoplasm Metastasis Carcinoma, Endometrioid Neoplasms, Glandular and Epithelial Lymphatic Metastasis Neoplasm Invasiveness Breast Neoplasms Lung Neoplasms Cystadenocarcinoma, Serous Neoplasms Carcinoma Pancreatic Neoplasms Prostatic Neoplasms Adenocarcinoma Liver Neoplasms Stomach Neoplasms Colonic Neoplasms Adenocarcinoma, Clear Cell Neoplasm Recurrence, Local Colorectal Neoplasms Genetic Predisposition to Disease Uterine Neoplasms Disease Progression Adenocarcinoma, Mucinous Endometrial Hyperplasia Genital Neoplasms, Female Peritoneal Neoplasms Skin Neoplasms Neoplasms, Multiple Primary Carcinoma, Squamous Cell Uterine Cervical Neoplasms Neoplasms, Cystic, Mucinous, and Serous Neoplasms, Second Primary Neovascularization, Pathologic Melanoma Kidney Neoplasms Thyroid Neoplasms Cell Transformation, Neoplastic Urinary Bladder Neoplasms Adenocarcinoma, Papillary Cystadenocarcinoma, Papillary Rectal Neoplasms Colorectal Neoplasms, Hereditary Nonpolyposis Carcinoma, Non-Small-Cell Lung Carcinoma, Papillary Neoplasms, Experimental Cystadenocarcinoma Gastrointestinal Neoplasms Esophageal Neoplasms Ascites Neoplasms, Hormone-Dependent Mouth Neoplasms Brain Neoplasms Head and Neck Neoplasms Mammary Neoplasms, Experimental Precancerous Conditions Neoplasms, Radiation-Induced Cystadenocarcinoma, Mucinous Disease Models, Animal Bone Neoplasms Carcinoma, Pancreatic Ductal Testicular Neoplasms Neoplastic Syndromes, Hereditary Carcinoma, Small Cell Adenoma Mixed Tumor, Mullerian Neoplastic Cells, Circulating Microsatellite Instability Fallopian Tube Neoplasms Pelvic Neoplasms Cystadenoma, Serous

Chemicals and Drugs48

Tumor Markers, Biological CA-125 Antigen Neoplasm Proteins Antineoplastic Agents DNA, Neoplasm RNA, Messenger Paclitaxel Cisplatin Tamoxifen Receptors, Estrogen Receptors, Progesterone Antigens, Neoplasm RNA, Small Interfering Estrogens Cancer Vaccines Antineoplastic Agents, Hormonal Receptor, erbB-2 BRCA2 Protein Antineoplastic Agents, Phytogenic Tumor Suppressor Protein p53 BRCA1 Protein RNA, Neoplasm Epididymal Secretory Proteins Tumor Suppressor Proteins Antibodies, Monoclonal Progestins Carboplatin MicroRNAs Contraceptives, Oral PTEN Phosphohydrolase Nuclear Proteins Proto-Oncogene Proteins Proto-Oncogene Proteins c-akt DNA-Binding Proteins Fluorouracil Transcription Factors Receptor, Epidermal Growth Factor Estrogen Receptor alpha Cadherins Estrogen Antagonists Prostate-Specific Antigen Antigens, Tumor-Associated, Carbohydrate Anticarcinogenic Agents Vascular Endothelial Growth Factor A Ki-67 Antigen Adaptor Proteins, Signal Transducing Carcinoembryonic Antigen Taxoids

Analytical, Diagnostic and Therapeutic Techniques and Equipment68

Neoplasm Staging Early Detection of Cancer Prognosis Immunohistochemistry Survival Analysis Survival Rate Retrospective Studies Risk Factors Neoplasm Transplantation Reverse Transcriptase Polymerase Chain Reaction Risk Antineoplastic Combined Chemotherapy Protocols Xenograft Model Antitumor Assays Follow-Up Studies Disease-Free Survival Hysterectomy Case-Control Studies Gene Expression Profiling Prospective Studies Blotting, Western Odds Ratio Kaplan-Meier Estimate Combined Modality Therapy Risk Assessment Treatment Outcome Transplantation, Heterologous Sensitivity and Specificity Neoplasm Grading Registries Incidence Lymph Node Excision Oligonucleotide Array Sequence Analysis Multivariate Analysis Tissue Array Analysis Tumor Burden Chemotherapy, Adjuvant Immunoenzyme Techniques Salpingectomy Cohort Studies Polymerase Chain Reaction Predictive Value of Tests Neoplasms, Experimental Logistic Models Drug Screening Assays, Antitumor Transfection Genetic Testing Molecular Targeted Therapy SEER Program Estrogen Replacement Therapy Tomography, X-Ray Computed Gene Knockdown Techniques Mammary Neoplasms, Experimental Confidence Intervals Questionnaires Reproducibility of Results Radiotherapy, Adjuvant DNA Mutational Analysis Flow Cytometry Clinical Trials as Topic Biopsy Drug Administration Schedule Disease Models, Animal Radiotherapy Models, Biological Body Mass Index Real-Time Polymerase Chain Reaction Hormone Replacement Therapy Palliative Care

Psychiatry and Psychology1

Phenomena and Processes51

Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Genetic Predisposition to Disease Genes, BRCA1 Risk Cell Proliferation Mutation Cell Movement Odds Ratio Germ-Line Mutation Apoptosis Sensitivity and Specificity DNA Methylation Postmenopause Genes, BRCA2 Cell Growth Processes Genotype Signal Transduction Cell Survival Down-Regulation Cell Division Gene Silencing Genes, Tumor Suppressor Up-Regulation Transfection Polymorphism, Genetic Time Factors Epithelial-Mesenchymal Transition Dose-Response Relationship, Drug Cell Cycle Promoter Regions, Genetic RNA Interference Menopause Gene Expression Base Sequence Genes, Neoplasm Microsatellite Repeats Genes, p53 Phenotype Parity Premenopause Alleles Cell Adhesion Loss of Heterozygosity Phosphorylation Tumor Microenvironment Body Mass Index Microsatellite Instability Diet Heterozygote Drug Synergism

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Information Science7

Survival Rate Registries Incidence SEER Program Questionnaires Base Sequence Molecular Sequence Data

Named Groups1

Health Care31

Survival Analysis Survival Rate Retrospective Studies Risk Factors Risk Follow-Up Studies Disease-Free Survival Case-Control Studies Prospective Studies Odds Ratio Kaplan-Meier Estimate Risk Assessment Treatment Outcome Sensitivity and Specificity Registries Age Factors Incidence Multivariate Analysis Cohort Studies Predictive Value of Tests Logistic Models Genetic Testing SEER Program Confidence Intervals National Cancer Institute (U.S.)Questionnaires Reproducibility of Results Clinical Trials as Topic Parity Body Mass Index Palliative Care

Geographicals4

United States China Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Vulvar Neoplasms Endometrial Neoplasms Ovarian Neoplasms Neoplasm Metastasis Carcinoma, Endometrioid Neoplasms, Glandular and Epithelial Lymphatic Metastasis Neoplasm Invasiveness Breast Neoplasms Cell Line, Tumor Lung Neoplasms Neoplasm Staging Gene Expression Regulation, Neoplastic Cystadenocarcinoma, Serous Early Detection of Cancer Prognosis Tumor Markers, Biological Neoplasms Carcinoma Pancreatic Neoplasms Mice, Nude CA-125 Antigen Prostatic Neoplasms Adenocarcinoma Neoplasm Proteins Antineoplastic Agents Immunohistochemistry Liver Neoplasms Stomach Neoplasms Survival Analysis Colonic Neoplasms Survival Rate Adenocarcinoma, Clear Cell Neoplasm Recurrence, Local Retrospective Studies Risk Factors Colorectal Neoplasms Neoplasm Transplantation Drug Resistance, Neoplasm Reverse Transcriptase Polymerase Chain Reaction Genetic Predisposition to Disease Genes, BRCA1 Uterine Neoplasms Disease Progression Risk Adenocarcinoma, Mucinous Antineoplastic Combined Chemotherapy Protocols Xenograft Model Antitumor Assays DNA, Neoplasm Cell Proliferation Endometrial Hyperplasia Follow-Up Studies Genital Neoplasms, Female Disease-Free Survival Tumor Cells, Cultured RNA, Messenger Peritoneal Neoplasms Hysterectomy Case-Control Studies Gene Expression Profiling Skin Neoplasms Paclitaxel Cisplatin Neoplasms, Multiple Primary Mutation Prospective Studies Carcinoma, Squamous Cell Cell Movement Uterine Cervical Neoplasms Blotting, Western Tamoxifen Receptors, Estrogen Odds Ratio Kaplan-Meier Estimate Combined Modality Therapy Receptors, Progesterone Antigens, Neoplasm Neoplasms, Cystic, Mucinous, and Serous Risk Assessment Germ-Line Mutation Neoplasms, Second Primary Treatment Outcome Transplantation, Heterologous Apoptosis Sensitivity and Specificity RNA, Small Interfering Endometrium Neovascularization, Pathologic Neoplasm Grading DNA Methylation Postmenopause Estrogens Cancer Vaccines Registries Genes, BRCA2 Melanoma Kidney Neoplasms Thyroid Neoplasms Cell Transformation, Neoplastic Urinary Bladder Neoplasms

No FAQ available that match "metastasis ovarian cancer endometrial cancer vulvar neoplasms"